Immunotherapy in lung cancer.

More research and new treatment options are needed in all stages of lung cancer. To this end immunotherapy needs a revival in view of recent improved technologies and greater understanding of the underlying biology. In this review we discuss mechanisms of tumour immunotherapy, non-specific, specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Moundhri, M., O'Brien, M., Souberbielle, B. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063029/
https://www.ncbi.nlm.nih.gov/pubmed/9703271
_version_ 1782137252925669376
author Al-Moundhri, M.
O'Brien, M.
Souberbielle, B. E.
author_facet Al-Moundhri, M.
O'Brien, M.
Souberbielle, B. E.
author_sort Al-Moundhri, M.
collection PubMed
description More research and new treatment options are needed in all stages of lung cancer. To this end immunotherapy needs a revival in view of recent improved technologies and greater understanding of the underlying biology. In this review we discuss mechanisms of tumour immunotherapy, non-specific, specific and adoptive, with particular reference to a direct therapeutic action on all subtypes of lung cancer.
format Text
id pubmed-2063029
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher Nature Publishing Group|1
record_format MEDLINE/PubMed
spelling pubmed-20630292009-09-10 Immunotherapy in lung cancer. Al-Moundhri, M. O'Brien, M. Souberbielle, B. E. Br J Cancer Research Article More research and new treatment options are needed in all stages of lung cancer. To this end immunotherapy needs a revival in view of recent improved technologies and greater understanding of the underlying biology. In this review we discuss mechanisms of tumour immunotherapy, non-specific, specific and adoptive, with particular reference to a direct therapeutic action on all subtypes of lung cancer. Nature Publishing Group|1 1998-08 /pmc/articles/PMC2063029/ /pubmed/9703271 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Al-Moundhri, M.
O'Brien, M.
Souberbielle, B. E.
Immunotherapy in lung cancer.
title Immunotherapy in lung cancer.
title_full Immunotherapy in lung cancer.
title_fullStr Immunotherapy in lung cancer.
title_full_unstemmed Immunotherapy in lung cancer.
title_short Immunotherapy in lung cancer.
title_sort immunotherapy in lung cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063029/
https://www.ncbi.nlm.nih.gov/pubmed/9703271
work_keys_str_mv AT almoundhrim immunotherapyinlungcancer
AT obrienm immunotherapyinlungcancer
AT souberbiellebe immunotherapyinlungcancer

Ejemplares similares